Idle JR et al., 2023-02-25: Review of ifosfamide history, efficacy and toxicity concluding that methylene blue appears generally effective for prevention and treatment of the encephalopathy, via MAO inhibition.
Methylene blue (MB) administration appears to be generally effective in the prevention and treatment of IIE, in all probability by the inhibition of monoamine oxidase in brain potentiating serotonin levels that modulate the effects of IFO on GABAergic and glutamatergic systems.
Idle JR et al., 2023-02-25: Review of ifosfamide history, efficacy and toxicity concluding that methylene blue appears generally effective for prevention and treatment of the encephalopathy, via MAO inhibition. C6. Study type: narrative review (Pharmacol Ther 2023;243:108366); Western New England University, USA. No patients. Authors declare no conflicts of interest. Note the mechanism it proposes (MAO inhibition raising serotonin) is the same mechanism the label warns can cause serotonin syndrome, which is the tension recorded in MTI-63. Study type: review.
